Distributor Claims AstraZeneca Engaged in Pay-for-Delay for Seroquel XR

Drug Industry Daily
A A
An antitrust lawsuit filed in a federal court in New York claims AstraZenica struck a deal with generic drugmakers to hold off on launching versions of its anti-psychotic drug Seroquel XR.

To View This Article:

Login

Subscribe To Drug Industry Daily